Impax International Sust Econ Inv PXINX

Medalist Rating as of | See Impax Investment Hub
  • NAV / 1-Day Return 11.75  /  −0.93 %
  • Total Assets 1.3 Bil
  • Adj. Expense Ratio
    0.700%
  • Expense Ratio 0.700%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.11%
  • Turnover 56%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:20 PM GMT+0

Morningstar’s Analysis PXINX

Will PXINX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Impax International Sust Econ Inv's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PXINX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 23.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.05 37.6 Mil
Healthcare

Novartis AG Registered Shares

2.69 33.2 Mil
Healthcare

AstraZeneca PLC

2.66 32.8 Mil
Healthcare

ASML Holding NV

2.64 32.6 Mil
Technology

HSBC Holdings PLC

2.40 29.6 Mil
Financial Services

Schneider Electric SE

2.19 27.0 Mil
Industrials

CSL Ltd

2.03 25.1 Mil
Healthcare

BNP Paribas Act. Cat.A

1.98 24.4 Mil
Financial Services

RELX PLC

1.89 23.3 Mil
Industrials

KDDI Corp

1.89 23.3 Mil
Communication Services

Sponsor Center